Grading strength of recommendations and quality of evidence in clinical guidelines: Report from an American College of Chest Physicians task force

Chest

Volumn 129, Issue 1, 2006, Pages 174-181

  Guyatt, Gordon ^a   Gutterman, David ^b   Baumann, Michael H ^c   Addrizzo Harris, Doreen ^d   Hylek, Elaine M ^e   Phillips, Barbara ^f   Raskob, Gary ^g   Lewis, Sandra Zelman ^h   Schünemann, Holger ⁱ  

^a MCMASTER UNIVERSITY   (Canada)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF KENTUCKY   (United States)

^g UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^h American College of Chest Physicians   (United States)

ⁱ NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Grading recommendations; Grading system; Methodology

Indexed keywords

COST BENEFIT ANALYSIS; HEALTH CARE COST; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; RESPIRATORY TRACT DISEASE; REVIEW; RISK BENEFIT ANALYSIS; TECHNIQUE;

EID: 33144490691     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.129.1.174     Document Type: Article

References (20)

1. Büller H, Agnelli G, Hull R, et al. Antithrombotic therapy for venous thromboembolic disease. Chest 2004; 126:401S-428S
2. Collins R, MacMahon S, Flather M, et al. Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials. BMJ 1996; 313:652-659
3. Guyatt G, Sinclair J, Cook D, et al. Grading recommendations: a qualitative approach. In: Guyatt GR, Rennie D, ed. Users' guide to the medical literature: a manual for evidence-based practice. Chicago, IL: AMA Press, 2002
4. Guyatt G, Straus S, McAlister F, et al. Incorporating patient values. In: Guyatt GR, Rennie D, ed. Users' guide to the medical literature: a manual for evidence-based practice. Chicago, IL: AMA Press, 2002
5. O'Connor A, Stacey D, Entwistle V, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev, Issue 2, (database online) 2003
6. Guyatt G, Montori V, Devereaux P, et al. Patients at the centre: in our practice, and in our use of language. ACP J Club 2004; 140:A11-A12
7. Goldstein R, Gort E, Guyatt G, et al. Economic analysis of respiratory rehabilitation. Chest 1997; 112:370-379
8. Devereaux P, Anderson D, Gardner M, et al. Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study. BMJ 2001; 323:1218-1222
9. Guyatt G, Baumann M, Pauker S, et al. Addressing resource allocation issues in recommendations from clinical guideline panels. Chest 2006; 129:182-187
10. Warkentin T, Greinacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126:311S-337S
11. Clagett G, Jackson M, Lip G, et al. Antithrombotic therapy in peripheral arterial occlusive disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126:609S-626S
12. Geerts W, Pineo G, Heit J, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126:338S-400S
13. de Bruijn S, Stam J. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke 1999; 30:484-488
14. Baudet E, Puel V, McBride J, et al. Long-term results of valve replacement with the St. Jude Medical prosthesis. J Thorac Cardiovasc Surg 1995; 109:858-870
15. Salem D, Stein P, Al-Ahmad A, et al. Antithrombotic therapy in valvular heart disease-native and prosthetic: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126:457S-482S
16. Devereaux P, Choi P, Lacchetti C, et al. A systematic review and meta-analysis of studies comparing mortality rates of private for-profit and private not-for-profit hospitals. CMAJ 2002; 166:1399-1406
17. Paramothayan S, Jones P. Corticosteroid therapy in pulmonary sarcoidosis: a systematic review. JAMA 2002; 287:1301-1307
18. Atkins D, Best D, Briss P, et al. Grading quality of evidence and strength of recommendations. BMJ 2004; 328:1490
19. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996; 348:1329-1339
20. Chong BH, Gallus AS, Cade JF, et al. Prospective randomised open-label comparison of danaparoid with dextran 70 in the treatment of heparin-induced thrombocytopenia with thrombosis: a clinical outcome study. Thromb Haemost 2001; 86:1170-1175